share_log

国药控股(01099.HK)获CITIC Securities Company Limited增持232.2万股普通股股份,价值约4,925.05万港元

Sinopharm (01099.HK) has been increased by CITIC Securities Company Limited by 2.322 million ordinary shares, valued at approximately 49.2505 million Hong Kong dollars.

Futu News ·  Nov 25 17:04

Reported on November 25th, according to the documents disclosed by the Hong Kong Stock Exchange on November 25th, CITIC Securities Company Limited increased its shareholding on November 20th at an average price of 21.2104 Hong Kong dollars per share.$SINOPHARM (01099.HK)$2.322 million shares of common stock, valued at approximately 49.2505 million Hong Kong dollars. After the shareholding, CITIC Securities Company Limited's latest number of shares held is 69.1936 million shares, and the holding ratio has increased from 4.98% to 5.16%.

HKEXAutoNews_CS20241125E00219.png

What is equity disclosure?

According to the requirements of the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the company's shares) must disclose their shareholding in the listed company. Directors and senior executives of the listed company must disclose their shareholding and equity certificate rights in the listed company and any related companies.

Why is equity disclosure important?

Equity disclosure enables investors to identify (1) individuals who control or have the ability to control the shareholding of the listed company and (2) individuals who may benefit from transactions involving entities related to the listed company.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment